advertisement
11.3.3 Apraclonidine, brimonidine (5)
Showing records 1 to 5
Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine
Search within classification 11.3.3 Apraclonidine, brimonidine11553 Effects of the preservative puriteR on the bioavailability of brimonidine in the aqueous humor of rabbits
Dong JQ; Babusis DM; Welty DF; Acheampong AA; Tang Liu D; Whitcup SM
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 285-292
11554 The comparative cardiovascular, pulmonary, ocular blood flow, and ocular hypotensive effects of topical travoprost, bimatoprost, brimonidine, and betaxolol
Inan UU; Ermis SS; Orman A; Onrat E; Yucel A; Ozturk F; Asagidag A; Celik A
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 293-310
11377 Effect of brimonidine tartrate 0.2% ophthalmic solution on pupil size
Kesler A; Shemesh G; Rothkoff L; Lazar M
Journal of Cataract and Refractive Surgery 2004; 30: 1707-1710
11307 Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy
Stewart WC; Stewart JA; Day DG; Sharpe ED; Jenkins JN
Eye 2004; 18: 990-995
11376 Miotic effect of brimonidine tartrate 0.15% ophthalmic solution in normal eyes
Thordsen JE; Bower KS; Warren BB; Stutzman R
Journal of Cataract and Refractive Surgery 2004; 30: 1702-1706
